Search - tctmd.com

Displaying 41 - 60 of 325

Sort: Relevancy | Date

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Presentation TCT 2024

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

Presenter: Bahram Yosofi

October 27, 2024

Presentation TCT 2024

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

Presenter: Andrew Hill

October 27, 2024

Presentation TCT 2024

TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs

Presenter: Sheref Elseidy

October 27, 2024

Presentation TCT 2024

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

Presenter: Oskar Angerås

October 27, 2024

Presentation TCT 2024

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Presenter: Shabiga Sivanesan

October 27, 2024

Presentation TCT 2024

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

Presenter: Guy Friedrich

October 27, 2024

Presentation TCT 2024

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

Presenter: Donna Lin

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Presentation TCT 2024

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

Presenter: Abhishek Chaturvedi

October 27, 2024

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

Presentation TCT 2023

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Presenter: Jennifer Rymer

October 26, 2023

Presentation TCT 2023

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

Presenter: Babar Basir

October 26, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

Presenter: Aakash Garg

October 25, 2023

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Advertisement

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content